BJA Advance Access originally published online on August 1, 2006
British Journal of Anaesthesia 2006 97(4):460-467; doi:10.1093/bja/ael191
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy—a porcine model
1 Division of General and Surgical Intensive Care Medicine, Innsbruck Medical University Anichstrasse 35, 6020 Innsbruck, Austria
2 Division of Anaesthesiology, Innsbruck Medical University Anichstrasse 35, 6020 Innsbruck, Austria
3 Department of Theoretical Surgery, Innsbruck Medical University Anichstrasse 35, 6020 Innsbruck, Austria
4 Department of Paediatrics, Innsbruck Medical University Anichstrasse 35, 6020 Innsbruck, Austria
5 Department of Histology and Embryology, Innsbruck Medical University Anichstrasse 35, 6020 Innsbruck, Austria
*Corresponding author. E-mail: dietmar.fries{at}uibk.ac.at
Background. This study was conducted to assess whether the combined administration of fibrinogen and prothrombin complex concentrate (PCC) enables the reversal of dilutional coagulopathy resulting from intended blood loss and fluid replacement, and whether this treatment reduces further blood loss and mortality.
Methods. In 20 anaesthetized pigs, 
65% of the estimated blood volume was withdrawn and replaced with the same amount of hydroxyethyl starch (6% HES 130/0.4) to mimic blood loss and to develop a dilutional coagulopathy. Pigs (randomized) received either fibrinogen (200 mg kg–1) and PCC (35 IU kg–1) (n=10), or placebo (n=10). Thereafter, a standard liver laceration was performed to induce uncontrolled haemorrhage. The subsequent blood loss and survival time were determined as primary outcome variables. Throughout the experiment serial blood samples were obtained to assess the competence of the haemostatic system using standard coagulation tests, modified Thrombelastograph® measurements (ROTEM®) and electron microscopy clot imaging.
Results. As compared with baseline, after haemodilution both groups showed statistically significant impairment of haemostasis as measured with standard coagulation tests and thrombelastography. These parameters significantly improved after administration of the study drugs while aPPT measurements remained unchanged. Blood loss after liver injury was significantly less in the treatment group as compared with placebo: 240 ml (50–830) vs 1800 ml (1500–2500) (P<0.0001). All treated animals survived, whereas 80% of the placebo group died (P<0.0001).
Conclusion. During haemodilution, substitution of fibrinogen and PCC causes an enhancement of coagulation and final clot strength. This reversal of dilutional coagulopathy may reduce blood loss and mortality when large amounts of colloids are needed to maintain normovolaemia during huge blood losses.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. T. Ganter and C. K. Hofer Coagulation Monitoring: Current Techniques and Clinical Use of Viscoelastic Point-of-Care Coagulation Devices Anesth. Analg., May 1, 2008; 106(5): 1366 - 1375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Dickneite, B. Doerr, and F. Kaspereit Characterization of the Coagulation Deficit in Porcine Dilutional Coagulopathy and Substitution with a Prothrombin Complex Concentrate Anesth. Analg., April 1, 2008; 106(4): 1070 - 1077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Haas, D. Fries, C. Holz, P. Innerhofer, W. Streif, A. Klingler, A. Hanke, and C. Velik-Salchner Less Impairment of Hemostasis and Reduced Blood Loss in Pigs After Resuscitation from Hemorrhagic Shock Using the Small-Volume Concept with Hypertonic Saline/Hydroxyethyl Starch as Compared to Administration of 4% Gelatin or 6% Hydroxyethyl Starch Solution Anesth. Analg., April 1, 2008; 106(4): 1078 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. G. Nielsen and J. H. Levy Fibrinogen and Bleeding: Old Molecule New Ideas Anesth. Analg., October 1, 2007; 105(4): 902 - 903. [Full Text] [PDF]
|
|
|
|
|
|
M. Mittermayr, W. Streif, T. Haas, D. Fries, C. Velik-Salchner, A. Klingler, E. Oswald, C. Bach, M. Schnapka-Koepf, and P. Innerhofer Hemostatic Changes After Crystalloid or Colloid Fluid Administration During Major Orthopedic Surgery: The Role of Fibrinogen Administration Anesth. Analg., October 1, 2007; 105(4): 905 - 917. [Abstract] [Full Text] [PDF]
|
|